A case report on the use of pirfenidone in the treatment of immune checkpoint inhibitorassociated pneumonia caused by pabrizumab
1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China
2.Department of Pulmonary and Critical Care Medicine, the Second People's Hospital of Guizhou Province, Guiyang 550002, Guizhou Province, China
3.Department of Pulmonary and Critical Care Medicine, Qinghai Red Cross Hospital, Xining 810015, Qinghai Province, China
收起